{"id":"NCT00422734","sponsor":"Eli Lilly and Company","briefTitle":"Tadalafil Taken Daily Compared to Placebo on Improvement of Getting and Maintaining an Erection and Sexual Quality of Life","officialTitle":"Tadalafil 5 mg Once a Day Compared to Placebo in Improving Erectile Dysfunction and Sexual Quality of Life","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-11","primaryCompletion":"2008-01","completion":"2008-01","firstPosted":"2007-01-17","resultsPosted":"2009-06-02","lastUpdate":"2009-06-10"},"enrollment":342,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Impotence"],"interventions":[{"type":"DRUG","name":"tadalafil","otherNames":["LY450190","Cialis","IC351"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"1","type":"PLACEBO_COMPARATOR"},{"label":"2","type":"ACTIVE_COMPARATOR"}],"summary":"To determine if tadalafil 5 mg daily compared to placebo when given for 12 weeks improves getting and maintaining an erection in men with erectile dysfunction and if there are improvements in the sexual quality of life of the man and his female study partner","primaryOutcome":{"measure":"Change From Baseline to Endpoint in the International Index of Erectile Function (IIEF)- Erectile Function Domain Score (Sum of IIEF Questions 1-5 and 15)","timeFrame":"Baseline and 12 weeks","effectByArm":[{"arm":"Placebo","deltaMin":0.49,"sd":0.781},{"arm":"Tadalafil","deltaMin":8.03,"sd":0.449}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"MALE","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":4},"locations":{"siteCount":19,"countries":["United States","Austria","France","Germany","Mexico"]},"refs":{"pmids":["24119319","23035781"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1},"commonTop":["Headache","Dyspepsia","Nasal congestion","Diarrhoea","Back pain"]}}